Literature DB >> 24912161

Profile of Bruce Levin.

Beth Azar.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24912161      PMCID: PMC4060679          DOI: 10.1073/pnas.1408161111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  8 in total

1.  Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections.

Authors:  Peter Ankomah; Bruce R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

2.  Coexistence of two asexual strains on a single resource.

Authors:  B R Levin
Journal:  Science       Date:  1972-03-17       Impact factor: 47.728

Review 3.  Short-sighted evolution and the virulence of pathogenic microorganisms.

Authors:  B R Levin; J J Bull
Journal:  Trends Microbiol       Date:  1994-03       Impact factor: 17.079

4.  Distribution of multilocus genotypes of Escherichia coli within and between host families.

Authors:  D A Caugant; B R Levin; R K Selander
Journal:  J Hyg (Lond)       Date:  1984-06

5.  Nasty viruses, costly plasmids, population dynamics, and the conditions for establishing and maintaining CRISPR-mediated adaptive immunity in bacteria.

Authors:  Bruce R Levin
Journal:  PLoS Genet       Date:  2010-10-28       Impact factor: 5.917

6.  Genetic diversity and temporal variation in the E. coli population of a human host.

Authors:  D A Caugant; B R Levin; R K Selander
Journal:  Genetics       Date:  1981-07       Impact factor: 4.562

7.  The population and evolutionary dynamics of phage and bacteria with CRISPR-mediated immunity.

Authors:  Bruce R Levin; Sylvain Moineau; Mary Bushman; Rodolphe Barrangou
Journal:  PLoS Genet       Date:  2013-03-14       Impact factor: 5.917

8.  Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids.

Authors:  Wenyan Jiang; Inbal Maniv; Fawaz Arain; Yaying Wang; Bruce R Levin; Luciano A Marraffini
Journal:  PLoS Genet       Date:  2013-09-26       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.